Bio-gate AG
Bio-Gate AG provides technologies and customized solutions for health and hygiene in Germany. The company offers HyProtect, a plasma coating which protects the surfaces of medical implants against bacterial colonization; and MicroSilver BG, an elemental microporous silver additive. It distributes its products to veterinarians and veterinary clinics. The company was incorporated in 2005 and is bas… Read more
Market Cap & Net Worth: Bio-gate AG (BIG1)
Bio-gate AG (XETRA:BIG1) has a market capitalization of $5.27 Million (€5.13 Million) as of March 19, 2026. Listed on the XETRA stock exchange, this Germany-based company holds position #33259 globally and #3745 in its home market, demonstrating a 0.91% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Bio-gate AG's stock price €0.56 by its total outstanding shares 9243691 (9.24 Million).
Bio-gate AG Market Cap History: 2025 to 2026
Bio-gate AG's market capitalization history from 2025 to 2026. Data shows growth from $7.73 Million to $5.27 Million (0.00% CAGR).
Bio-gate AG Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Bio-gate AG's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of BIG1 by Market Capitalization
Companies near Bio-gate AG in the global market cap rankings as of March 19, 2026.
Key companies related to Bio-gate AG by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #98 globally with a market cap of $170.40 Billion USD.
- EssilorLuxottica Société anonyme (PINK:ESLOF): Ranked #263 globally with a market cap of $78.22 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #362 globally with a market cap of $61.18 Billion USD ( €59.61 Billion EUR).
- Becton Dickinson and Company (NYSE:BDX): Ranked #472 globally with a market cap of $45.90 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #98 | Intuitive Surgical Inc | NASDAQ:ISRG | $170.40 Billion | $482.76 |
| #263 | EssilorLuxottica Société anonyme | PINK:ESLOF | $78.22 Billion | $265.00 |
| #362 | EssilorLuxottica S. A. | PA:EL | $61.18 Billion | €203.00 |
| #472 | Becton Dickinson and Company | NYSE:BDX | $45.90 Billion | $161.64 |
Bio-gate AG Historical Marketcap From 2025 to 2026
Between 2025 and today, Bio-gate AG's market cap moved from $7.73 Million to $ 5.27 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €5.27 Million | -31.90% |
| 2025 | €7.73 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Bio-gate AG was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.27 Million USD |
| MoneyControl | $5.27 Million USD |
| MarketWatch | $5.27 Million USD |
| marketcap.company | $5.27 Million USD |
| Reuters | $5.27 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.